शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SOLARINDSNSESolar Industries India Limited· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 7 Aug, 2025 · 17:25 IST

Solar Industries India Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

Revenue Growth 20pctPat Growth 25pctEbitda Margin CompressionResults RestatedResults View source PDFExplain this filing

SOLARINDS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.0%Reaction day
₹14919.00
prior close
₹14950.00
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)-1.0%-2.0% vs market
Chemicals & Petrochemicals peers, median of 185sector · industry level-1.1%-1.9% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty 100 and 1.9 pts less than its Chemicals & Petrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.8
10m
-3.7
15m
-2.5
30m
-1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.0-1.0-2.0-1.1-1.9
Next day
-0.5-0.1-0.4-0.6+0.2
2d
-2.2-0.4-1.8-1.2-1.0
3d
+0.9+0.2+0.7-0.4+1.2
4d
+1.0+0.2+0.8-1.2+2.3
5d
+0.4+1.2-0.8-0.3+0.7
1w
-3.0+2.0-5.0+0.3-3.3
15d
-6.0+0.1-6.2-0.8-5.2
1m
-6.6+0.9-7.4+0.3-6.8
2m
-6.2+2.0-8.2-2.6-3.6
3m
-10.3+4.2-14.5-5.4-4.9
UpDownMarket · Nifty 100Sector · Chemicals & Petrochemicals peers, median of 185Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Solar Industries India reported strong Q1 FY26 results. Consolidated revenue from operations rose to ₹2,154.45 crores, up about 27.9% year-on-year from ₹1,684.80 crores. Consolidated net profit grew to ₹352.62 crores versus ₹300.54 crores last year, with EPS at ₹37.43 (₹31.66 prior year). On a standalone basis, revenue jumped to ₹1,387.15 crores (up ~32.8%) and net profit climbed to ₹279.52 crores (up ~43.9%). Consolidated operating margin softened to 22.23% from 24.42% a year ago, partly due to a ₹17.89 crore hyperinflation adjustment for Turkey subsidiaries under Ind AS 29. The company also finalised purchase price allocation for its South Africa Problast acquisition, restating prior period figures and booking goodwill of ₹117.27 crores.

Likely market impact

Healthy top-line and earnings growth on both consolidated and standalone basis, reinforcing business momentum. Margin compression on the consolidated side and restated prior numbers are minor watchpoints but the overall print is positive for shareholders.